-
-
-
-
-
-
-
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
-
-
-
-
-
-
-
Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss of $1.15
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

